Hans Wedel
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Blood Pressure and Hypertension Studies 54
- Heart Failure Treatment and Management 36
- Cardiovascular Function and Risk Factors 32
- Acute Myocardial Infarction Research 24
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
- Hormonal Regulation and Hypertension 25
- Co-authors
- Deborah A. Marshall (2 shared papers)O. Johnell (1 shared paper)Lars Wilhelmsen (66 shared papers)Sverre E. Kjeldsen (28 shared papers)Markku S. Nieminen (27 shared papers)Stevo Julius (17 shared papers)Björn Dahlöf (26 shared papers)Gareth Beevers (21 shared papers)
- Journals
- European Heart Journal (20 papers)Journal of Hypertension (17 papers)Journal of the American College of Cardiology (13 papers)Circulation (10 papers)Journal of Internal Medicine (10 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Hans Wedel
262 papers receiving 41.3k citations
Hans Wedel's Hit Papers
Peers
Comparison fields: 5 of 192
- Cardiology and Cardiovascular Medicine 21.7k
- Endocrinology, Diabetes and Metabolism 15.0k
- Surgery 14.7k
- Orthopedics and Sports Medicine 2.6k
- Pharmacy 1.4k
Countries citing papers authored by Hans Wedel
This map shows the geographic impact of Hans Wedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Wedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Wedel more than expected).
Fields of papers citing papers by Hans Wedel
This network shows the impact of papers produced by Hans Wedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Wedel. The network helps show where Hans Wedel may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Wedel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 268 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Hit paper breakdown → | 1998 | 4035 |
| 2 | Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Hit paper breakdown → | 2002 | 3908 |
| 3 | Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery Hit paper breakdown → | 2004 | 3249 |
| 4 | Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures Hit paper breakdown → | 1996 | 2810 |
| 5 | Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Hit paper breakdown → | 2003 | 2712 |
| 6 | Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Hit paper breakdown → | 2005 | 1907 |
| 7 | Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year Hit paper breakdown → | 1995 | 1096 |
| 8 | Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Hit paper breakdown → | 2002 | 1094 |
| 9 | EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION Hit paper breakdown → | 1981 | 781 |
| 10 | Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Hit paper breakdown → | 2005 | 728 |
| 11 | Excess Mortality among Persons with Type 2 Diabetes Hit paper breakdown → | 2015 | 721 |
| 12 | Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications Hit paper breakdown → | 2014 | 697 |
| 13 | Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction Hit paper breakdown → | 1992 | 676 |
| 14 | Glycemic Control and Excess Mortality in Type 1 Diabetes Hit paper breakdown → | 2014 | 673 |
| 15 | Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Hit paper breakdown → | 1999 | 621 |
| 16 | Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects Hit paper breakdown → | 2012 | 547 |
| 17 | Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections Hit paper breakdown → | 2017 | 529 |
| 18 | 1999 | 493 | |
| 19 | 1998 | 478 | |
| 20 | Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Hit paper breakdown → | 1990 | 461 |
About Hans Wedel
Hans Wedel is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Economics and Econometrics and Public Health, Environmental and Occupational Health, having authored 268 papers that have together received 44.2k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (54 papers), Lipoproteins and Cardiovascular Health (44 papers), Heart Failure Treatment and Management (36 papers), Health Systems, Economic Evaluations, Quality of Life (33 papers), Cardiovascular Function and Risk Factors (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Hormonal Regulation and Hypertension (25 papers) and Acute Myocardial Infarction Research (24 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (21.7k citations), Endocrinology, Diabetes and Metabolism (15.0k citations), Surgery (14.7k citations), Orthopedics and Sports Medicine (2.6k citations) and Pharmacy (1.4k citations). Hans Wedel has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Deborah A. Marshall, O. Johnell, Lars Wilhelmsen, Sverre E. Kjeldsen, Markku S. Nieminen, Stevo Julius, Björn Dahlöf, Gareth Beevers, Dag Elmfeldt and Lars Sjöström. Their work appears in journals such as European Heart Journal, Journal of Hypertension, Journal of the American College of Cardiology, Circulation and Journal of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.